Guidelines for practical use of MAL-PDT in non-melanoma skin cancer

被引:74
作者
Christensen, E. [1 ]
Warloe, T. [2 ]
Kroon, S. [3 ]
Funk, J. [4 ]
Helsing, P. [5 ]
Soler, A. M. [6 ]
Stang, H. J. [7 ]
Vatne, O. [8 ]
Mork, C. [5 ]
机构
[1] Norwegian Univ Sci & Technol, Dept Dermatol, St Olavs Univ Hosp HF, Inst Canc Res & Mol Med,Fac Med,NTNU, N-7034 Trondheim, Norway
[2] Oslo Univ Hosp, Rikshosp, Dept Surg, Oslo, Norway
[3] Stavanger Univ Hosp, Dept Dermatovenereol, Div Surg, Helse Stavanger HF, Stavanger, Norway
[4] Dr Funks Hudklin, Moss, Norway
[5] Oslo Univ Hosp, Rikshosp, Dept Dermatol, Oslo, Norway
[6] Oslo Univ Hosp, Photodynam Out Patients Clin, Dept Surg, Rikshosp,Aleris Med Ctr, Oslo, Norway
[7] Holdbergsplads Legesenter, Oslo, Norway
[8] Cent Hosp, Forde, Norway
关键词
aminolaevulinic acid; guidelines; methyl aminolaevulinic acid; non-melanoma skin cancer; procedural PDT; topical photodynamic therapy; BASAL-CELL CARCINOMA; TOPICAL PHOTODYNAMIC THERAPY; METHYL AMINOLEVULINATE; 5-AMINOLEVULINIC ACID; ACTINIC KERATOSIS; DOUBLE-BLIND; BOWENS-DISEASE; PAIN RELIEF; TRANSPLANT RECIPIENTS; PROTOPORPHYRIN-IX;
D O I
10.1111/j.1468-3083.2009.03430.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Methyl aminolaevulinate photodynamic therapy is increasingly practiced in the treatment of actinic keratoses, Bowen's disease and basal cell carcinomas. This method is particularly suitable for treating multiple lesions, field cancerization and lesions in areas where a good cosmetic outcome is of importance. Good treatment routines will contribute to a favourable result. The Norwegian photodynamic therapy (PDT) group consists of medical specialists with long and extensive PDT experience. With support in the literature, this group presents guidelines for the practical use of topical PDT in non-melanoma skin cancer.
引用
收藏
页码:505 / 512
页数:8
相关论文
共 50 条
[41]   Current Role of Radiotherapy in Non-melanoma Skin Cancer [J].
Veness, M. J. ;
Delishaj, D. ;
Barnes, E. A. ;
Bezugly, A. ;
Rembielak, A. .
CLINICAL ONCOLOGY, 2019, 31 (11) :749-758
[42]   Epigenetic regulation in the pathogenesis of non-melanoma skin cancer [J].
Kashyap, Mahendra Pratap ;
Sinha, Rajesh ;
Mukhtar, M. Shahid ;
Athar, Mohammad .
SEMINARS IN CANCER BIOLOGY, 2022, 83 :36-56
[43]   Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer [J].
Karimi, K. ;
Lindgren, T. H. ;
Koch, C. A. ;
Brodell, Robert T. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03) :389-403
[44]   Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer [J].
K. Karimi ;
T. H. Lindgren ;
C. A. Koch ;
Robert T. Brodell .
Reviews in Endocrine and Metabolic Disorders, 2016, 17 :389-403
[45]   Photodynamic therapy of non-melanoma skin cancers [J].
Ikram, M. ;
Khan, R. U. ;
Firdous, S. ;
Atif, M. ;
Nawaz, M. .
LASER PHYSICS, 2011, 21 (02) :427-433
[46]   Photodynamic Therapy for Non-Melanoma Skin Cancers [J].
Cohen, Diana K. ;
Lee, Peter K. .
CANCERS, 2016, 8 (10)
[47]   Current therapy of non-melanoma skin cancer [J].
Schlaak, M. ;
von Bartenwerffer, W. ;
Mauch, C. .
HAUTARZT, 2011, 62 (06) :430-435
[48]   Photodynamic therapy for non-melanoma skin cancer [J].
Szeimies, RM ;
Morton, CA ;
Sidoroff, A ;
Braathen, LR .
ACTA DERMATO-VENEREOLOGICA, 2005, 85 (06) :483-490
[49]   Prevention of non-melanoma skin cancer. [J].
Stratton S.P. .
Current Oncology Reports, 2001, 3 (4) :295-300
[50]   Update of cetuximab for non-melanoma skin cancer [J].
Wollina, Uwe .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) :271-276